Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|February 13, 2024
A more efficient method for generating glioblastoma-multiforme model in mice using genome editing technologyNaoki Ohtsu, Shota KatayamaAngewandte Chemie (International Ed. in English)|April 16, 2016
A Powerful CRISPR/Cas9-Based Method for Targeted Transcriptional ActivationShota Katayama, Tetsuo Moriguchi, Naoki Ohtsu, et al.Experimental Cell Research|October 27, 2006
Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesisNaoki Ohtsu, Ikuo Nobuhisa, Miyuki Mochita, et al.Experimental Cell Research|February 6, 2007
Identification of a population of cells with hematopoietic stem cell properties in mouse aorta-gonad-mesonephros culturesIkuo Nobuhisa, Naoki Ohtsu, Seiji Okada, et al.Cancer Research|December 19, 2015
Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-κB Signaling PathwayNaoki Ohtsu, Yuka Nakatani, Daisuke Yamashita, et al.Plos One|March 24, 2015
p38 MAP kinase inhibitor suppresses transforming growth factor-β2-induced type 1 collagen production in trabecular meshwork cellsMiyuki Inoue-Mochita, Toshihiro Inoue, Tomokazu Fujimoto, et al.FEBS Letters|June 29, 2010
Involvement of the Hipk family in regulation of eyeball size, lens formation and retinal morphogenesisToshihiro Inoue, Tetsushi Kagawa, Miyuki Inoue-Mochita, et al.Cancer Research|August 5, 2015
Ceacam1L Modulates STAT3 Signaling to Control the Proliferation of Glioblastoma-Initiating CellsSadahiro Kaneko, Yuka Nakatani, Tatsuya Takezaki, et al.Stem Cells (Dayton, Ohio)|April 20, 2016
Chemical Screening Identifies EUrd as a Novel Inhibitor Against Temozolomide-Resistant Glioblastoma-Initiating CellsYoshihiro Tsukamoto, Naoki Ohtsu, Smile Echizenya, et al.Pageof 1